Hypoxia-suppressed Dicer and AGO1 promote angiogenesis Hypoxia-induced angiogenesis is a critical and complex process in normal development and disease conditions such as ischemia. In response to hypoxia, vascular endothelial cells (ECs) selectively upregulate a panel of angiogenic molecules through an intricately coordinated network consisting of transcriptional and post-transcriptional controls to support angiogenesis and new vessel formation. MicroRNAs (miRNAs or miRs) have emerged as essential regulators that modulate gene expression at post-transcriptional level. The regulatory mechanisms of miRNAs and their functional relevance have been intensively investigated in cardiovascular biology and other fields. Most studies to date have focused on transcriptional regulation of miRNAs and functional validation of single miRNA-single target pathways. I recently demonstrated that hypoxia induces a group of hypoxia-responsive miRNAs (HRMs) including Let-7 and miR-103/107, which jointly suppress Dicer and Argonaute 1 (AGO1), two key components of miRNA machinery. The marked decrease of Dicer and AGO1 indicate that hypoxia may cause a global reprogramming of miRNA biogenesis and targeting at post- transcriptional level. Gain- and loss-of-function experiments provide evidence that hypoxia- suppressed Dicer and AGO1 enhance expression of angiogenic factors in ECs, e.g. vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and placental growth factor (PlGF) and hence promote angiogenesis. Mechanistically, hypoxia-suppressed Dicer may alter miRNA biogenesis to promote selective processing of HRMs, which acts in concert with hypoxia- suppressed AGO1 to decrease the miRISC targeting of angiogenic molecules. These observations prompted me to hypothesize that hypoxia-suppressed Dicer and AGO1 alter miRNA biogenesis and miRNA targeting, which enhances the expression of genes promoting angiogenesis. To test this hypothesis, I proposed three specific aims:
In Aim 1, I will investigate the molecular basis by which the hypoxia-suppressed Dicer reprograms miRNA biogenesis in ECs to enhance the expression of angiogenic molecules.
In Aim 2, I will delineate the mechanism by which hypoxia- suppressed AGO1 regulates miRNA targetome in ECs to promote angiogenesis.
In Aim 3, I will examine the functional relevance of hypoxia-suppressed Dicer and AGO1 in pathological angiogenesis, i.e., in the context of myocardial ischemia. Collectively, these studies will reveal a new paradigm of miRNA-regulated gene expression in ECs responding to hypoxic and ischemic stress. Furthermore, the delineated pathways may provide novel insights into future translational studies involving pathological angiogenesis.

Public Health Relevance

Hypoxia (i.e. low oxygen conditions)-induced angiogenesis is a critical adaptation of vascular endothelial cells in development and many disease conditions, such as ischemia. The proposed study aims at elucidating a novel mechanism by which microRNAs, a novel group of gene regulators, and their processing proteins, mediate this functional change. The research project will enhance our understanding of hypoxia- related physiological changes and pathological progression, as well as provide new therapeutic opportunities in treating ischemic diseases, e.g. myocardial ischemia and peripheral vascular diseases.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Career Transition Award (K99)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-P (F1))
Program Officer
Wang, Wayne C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Diego
Internal Medicine/Medicine
Schools of Medicine
La Jolla
United States
Zip Code
Zhang, Jiao; Dong, Jianjie; Martin, Marcy et al. (2018) AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension. Am J Respir Crit Care Med 198:509-520
He, Ming; Chen, Zhen; Martin, Marcy et al. (2017) miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease. Circ Res 120:354-365
Guo, Wenjie; Liu, Wen; Chen, Zhen et al. (2017) Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis. Nat Commun 8:2168
Liu, Wen; Guo, Wenjie; Shen, Lihong et al. (2017) T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice. Oncotarget 8:7586-7597
Ajami, Nassim E; Gupta, Shakti; Maurya, Mano R et al. (2017) Systems biology analysis of longitudinal functional response of endothelial cells to shear stress. Proc Natl Acad Sci U S A 114:10990-10995
Lin, Ting-Yang; Wei, Tong-You Wade; Li, Shuai et al. (2016) TIFA as a crucial mediator for NLRP3 inflammasome. Proc Natl Acad Sci U S A 113:15078-15083
Shang, Fenqing; Zhang, Jiao; Li, Zhao et al. (2016) Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade. PLoS One 11:e0151845
Chen, Zhen; Wen, Liang; Martin, Marcy et al. (2015) Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a. Circulation 131:805-14
Cooke, John P; Chen, Zhen (2015) A compendium on peripheral arterial disease. Circ Res 116:1505-8
Chen, Zhen; Martin, Marcy; Li, Zhao et al. (2014) Endothelial dysfunction: the role of sterol regulatory element-binding protein-induced NOD-like receptor family pyrin domain-containing protein 3 inflammasome in atherosclerosis. Curr Opin Lipidol 25:339-49